Irregular tick-borne encephalitis vaccination schedules: The effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study

Vaccine

Volumn 32, Issue 20, 2014, Pages 2375-2381

  Schosser, Rudolf ^a,g   Reichert, Anja ^b   Mansmann, Ulrich ^c   Unger, Bernd ^d   Heininger, Ulrich ^e   Kaiser, Reinhard ^f  

^a Baxter Deutschland GmbH   (Germany)

^b Baxter Deutschland GmbH   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d BAXTER BIOSCIENCE   (Austria)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^f Klinikum Pforzheim GmbH   (Germany)

^g Medconpharm GmbH   (Germany)

Author keywords

Delayed TBE vaccination; Irregular scheme; Reestablish protection

Indexed keywords

TICK BORNE ENCEPHALITIS VACCINE;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CHILD; FLU LIKE SYNDROME; GERMANY; GROUPS BY AGE; HUMAN; INJECTION SITE INFLAMMATION; NORMAL HUMAN; OPEN STUDY; PATIENT HISTORY OF THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; THERAPY DELAY; TICK BORNE ENCEPHALITIS;

DELAYED TBE VACCINATION; IRREGULAR SCHEME; REESTABLISH PROTECTION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; ENCEPHALITIS, TICK-BORNE; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VIRAL VACCINES; YOUNG ADULT;

EID: 84897495656     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.01.072     Document Type: Article

References (27)

1. Kollaritsch H., Paulke-Korinek M., Holzmann H., Hombach J., Bjorvatn B., Barrett A. Vaccines and vaccination against tick-borne encephalitis. Expert Rev Vaccines 2012, 11(9):1103-1119.
2. Süss J. Tick-borne encephalitis 2010: epidemiology; endemic areas; and virus strains in Europe and Asia - an overview. Ticks Tick Borne Dis 2011, 2(1):2-15.
3. European Centre for Disease Prevention and Control Epidemiological situation of tick-borne encephalitis in the European Union and European Free Trade Association countries 2012, ECDC, Stockholm.
4. Heinz F.X., Holzmann H., Essl A., Kundi M. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine 2007, 25(43):7559-7567.
5. Heinz F.X., Stiasny K., Holzmann H., Grgic-Vitek M., Kriz B., Essl A., et al. Vaccination and tick-borne encephalitis, Central Europe. Emerg Infect Dis 2013, 19(1):69-76.
6. Löw-Baselli A., Konior R., Pavlova B.G., Fritsch S., Poellabauer E., Maritsch F., et al. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies. Vaccine 2006, 24(24):5256-5263.
7. ® Junior. Hum Vaccin Immunother 2012, 8(6):736-742.
8. Wittermann C., Schöndorf I., Gniel D. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules. Vaccine 2009, 27(10):1661-1666.
9. ® vaccines: review of a clinical development programme. Vaccine 2011, 29(43):7307-7319.
10. Askling H.H., Vene S., Rombo L., Lindquist L. Immunogenicity of delayed TBE-vaccine booster. Vaccine 2012, 30(3):499-502.
11. Rendi-Wagner P., Kundi M., Zent O., Banzhoff A., Jaehnig P., Stemberger R., et al. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation. Vaccine 2004, 23(3):427-434.
12. Bundesinstitut für Arzneimittel und Medizinprodukte Empfehlungen zur Planung, Durchführung und Auswertung von Anwendungsbeobachtungen November 1998.
13. Summary of Product Characteristics: FSME-Immun. 9[At/H/001-002/II/30G]. 21-3-2013. FSME-Immun.
14. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2012. Epidemiol Bull 2012, 30:283-310.
15. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases General recommendations on immunization - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011, 60(2):1-64.
16. Baldovin T., Mel R., Bertoncello C., Carpenè G., Soppelsa F., Giliberti A., et al. Persistence of immunity to tick-borne encephalitis after vaccination and natural infection. J Med Virol 2012, 84(8):1274-1278.
17. Hainz U., Jenewein B., Asch E., Pfeiffer K.P., Berger P., Grubeck-Loebenstein B. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 2005, 23(25):3232-3235.
18. Paulke-Korinek M., Rendi-Wagner P., Kundi M., Laaber B., Wiedermann U., Kollaritsch H. Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection. Vaccine 2009, 27(50):7027-7030.
19. Paulke-Korinek M., Kundi M., Laaber B., Brodtraeger N., Seidl-Friedrich C., Wiedermann U., et al. Factors associated with seroimmunity against tick borne encephalitis virus 10 years after booster vaccination. Vaccine 2013, 31(9):1293-1297.
20. Rendi-Wagner P., Kundi M., Zent O., Dvorak G., Jaehnig P., Holzmann H., et al. Persistence of protective immunity following vaccination against tick-borne encephalitis-longer than expected?. Vaccine 2004, 22(21-22):2743-2749.
21. Rendi-Wagner P., Paulke-Korinek M., Kundi M., Wiedermann U., Laaber B., Kollaritsch H. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up. Vaccine 2007, 25(27):5097-5101.
22. Weinberger B., Keller M., Fischer K.H., Stiasny K., Neuner C., Heinz F.X., et al. Decreased antibody titers and booster responses in tick-borne encephalitis vaccines aged 50-90 years. Vaccine 2010, 28(20):3511-3515.
23. ® 0.5ml in adults aged 18-67 years. Hum Vaccin 2009, 5(8):551-556.
24. Stiasny K., Aberle J.H., Keller M., Grubeck-Loebenstein B., Heinz F.X. Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis. PLoS ONE 2012, 7(3):e34145.
25. Schöndorf I., Schönfeld C., Nicolay U., Zent O., Banzhoff A. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule. Int J Med Microbiol 2006, 296(Suppl 40):208-212.
26. Höfer T., Muehlinghaus G., Moser K., Yoshida T., Mei H.E., Hebel K., et al. Adaptation of humoral memory. Immunol Rev 2006, 211:295-302.
27. Radbruch A., Muehlinghaus G., Luger E.O., Inamine A., Smith K.C.G., Dörner T., et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006, 6(10):741-750.